<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">DULOXETINE HYDROCHLORIDE</span><br/>(du-lox'e-teen)<br/><span class="topboxtradename">Cymbalta<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">psychotherapeutic agent</span>; <span class="classification">antidepressant</span>; <span class="classification">serotonin norepinephrine reuptake inhibitor (snri)</span><br/><b>Prototype: </b>Venlafaxine<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>20 mg, 30 mg, 60 mg capsules</p>
<h1><a name="action">Actions</a></h1>
<p>Exact mechanism of action in controlling depression or pain is unknown. As a selective serotonin and norepinephrine reuptake
         inhibitor (SSNRI), duloxetine causes potentiation of serotonergic and noradrenergic activity in the CNS.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Antidepressant effect is presumed to be due to its dual inhibition of CNS presynaptic neuronal uptake of serotonin and norepinephrine,
         thus increasing the serum levels of both substances.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of major depression, diabetic peripheral neuropathy.</p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Chronic pain syndromes.<b></b>
</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>MAOI therapy; uncontrolled narrow-angle glaucoma; abrupt discontinuation; pregnancy (category C), lactation. Safety and efficacy
         in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Anorexia nervosa, history of mania, history of suicidal ideation; cardiac or hepatic disease; renal impairment or renal failure;
         hypertension.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Depression</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 4060 mg/d in one or two divided doses<br/><br/><span class="indicationtitle">Diabetic Neuropathy or Chronic Pain</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 60 mg/d in one or two divided doses<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Do not initiate therapy within 14 d of the last dose of an <small>MAOI</small>.
         </li>
<li>Must be swallowed whole. Do not cut, chew, or crush. Do not sprinkle on food or mix with liquids.</li>
<li>Store at 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Fatigue, hot flashes. <span class="typehead">CNS:</span> Dizziness, somnolence, tremor, <span class="speceff-common">insomnia</span>
<i>.</i>
<span class="typehead">GI:</span>
<span class="speceff-common">Nausea, dry mouth, constipation</span>
<i>,</i> diarrhea, vomiting. <span class="typehead">Metabolic:</span> Decreased appetite, weight loss. <span class="typehead">Skin:</span> Increased sweating. <span class="typehead">Special Senses:</span> Blurred vision. <span class="typehead">Urogenital:</span> Decreased libido, abnormal orgasm, erectile dysfunction, ejaculatory dysfunction. Cholestatic jaundice and hepatitis. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Alcohol</b> may result in increased liver function tests; <span class="classification">maois</span> may result in hyperthermia, rigidity, mental status changes, myoclonus, autonomic instability, features resembling neuroleptic
      malignant syndrome; <b>cimetidine, fluoxetine, fluvoxamine, paroxetine, quinidine</b>
<b>,</b>
<span class="classification">quinolones</span> may increase levels and half-life of duloxetine; may increase levels and toxicity of <b>thioridazine</b>
<b>,</b>
<span class="classification">tricyclic antidepressants</span>. <b>Amphetamine, dextroamphetamine, buspirone, cocaine, dexfenfluramine, fenfluramine, lithium, phentermine, sibutramine, nefazodone</b>
<b>,</b>
<span class="classification">ssri</span>s, <span class="classification">triptans</span>, <b>tramadol, trazodone</b> may cause serotonin syndrome. <span class="typehead">Herbal:</span>
<b>St. John's Wort, tryptophan</b> may cause serotonin syndrome. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead"> Peak:</span>  6 h. <span class="typehead">Metabolism:</span> Metabolized in the liver by CYP2D6 and CYP1A2. <span class="typehead">Elimination:</span> 70% excreted in urine, 20% excreted in feces. <span class="typehead">Half-Life:</span> 12 h (817 h). 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Ensure that a complete list of all concurrent medications is obtained.</li>
<li>Monitor for S&amp;S of numerous drug-drug interactions (see Interaction section).</li>
<li>Lab test: LFTs for unexplained abdominal pain or enlarged liver.</li>
<li>Monitor closely for and report suicide ideation, especially when drug is initiated or dosage changed.</li>
<li>Report emergence of any of the following: anxiety, agitation, panic attacks, insomnia, irritability, hostility, psychomotor
            restlessness, hypomania, and mania.
         </li>
<li>Monitor BP, especially in those being treated for hypertension.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>The beneficial effects of this drug may not be felt for approximately 4 wk.</li>
<li>Report any of the following: suicidal ideation (especially early in treatment or when dosage is changed), palpitations, anxiety,
            hyperactivity, agitation, panic attacks, insomnia, irritability, hostility, restlessness.
         </li>
<li>Do not abruptly discontinue taking this drug. Notify physician if side effects are bothersome.</li>
<li>Avoid or minimize use of alcohol while taking this drug.</li>
<li>Do not self-treat for coughs, colds, or allergies. Consult physician.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>